Karina Sultankulova: Smarter D-Dimer Strategies for Safe and Efficient DVT Exclusion
Karina Sultankulova, Clinical Director at American Medical Centers, shared on LinkedIn about a recent article by Menno V Huisman and Kenneth A Bauer, published in UpToDate, addinag:
”In clinical practice, ruling out Deep Vein Thrombosis (DVT) using a fixed D-dimer cutoff of 500 ng/mL often leads to over-testing, especially in older adults where baseline levels naturally rise.
Modern, evidence-based strategies allow us to safely optimize efficiency without compromising patient safety:
1. Age-adjusted cutoff
For patients >50 years old with a low/moderate pretest probability, use the following validated formula:
Age (years) x 10 ng/mL
The evidence:
Data from a multicenter prospective study of 3,205 patients showed that this approach safely ruled out DVT without compression ultrasonography (CUS).
At 3 months, there were zero VTE events in patients who fell between the fixed 500 ng/mL and their higher age-adjusted limit.
The impact: In patients ≥75 yo, it tripled the number of people who could safely avoid unnecessary imaging (16% vs. 5% using the conventional cutoff), significantly increasing specificity.
2. Pretest probability (PTP)-Adjusted Cutoff
This strategy adjusts the D-dimer threshold based on clinical risk assessment (e.g., Wells Score):
Low PTP: DVT is excluded if D-dimer is <1000 ng/mL.
Moderate PTP: DVT is excluded if D-dimer is <500 ng/mL.
The Impact: Clinical studies show this reduces the overall need for ultrasound scans by 8% to 47%, maintaining an incredibly safe missed-thrombosis rate of less than 0.6% during follow-up.
Key takeaway:
Adopting adjusted D-dimer cutoffs reduces unnecessary diagnostic imaging, lowers healthcare costs, and spares elderly patients from redundant hospital stress – all while safely excluding thromboembolic events.”
Title: Clinical presentation and diagnosis of the nonpregnant adult with suspected deep vein thrombosis of the lower extremity
Authors: Menno V Huisman, Kenneth A Bauer

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 13, 2026, 12:50Cornelia Englisch: Insights Into Clonal Hematopoiesis and Thrombosis Risk at EHA 2026
-
Jun 13, 2026, 11:18Mavis Agnes Kisakye: Transforming Lives Through the WFH Humanitarian Aid Program in Uganda
-
Jun 13, 2026, 10:48Humberto Cruz Esparra: Stroke Recovery Is More Than Regaining Function
-
Jun 13, 2026, 10:34Kelvin Hill: The Updated Stroke Clinical Care Standard Is Out Now
-
Jun 13, 2026, 10:04Johanna Gebhart: New Publication from the Vienna Bleeding Biobank Advancing BDUC Research Is Now Live
-
Jun 13, 2026, 08:50Alfadil Haroon: Decoding the Complexity of Factor II Deficiency at EHA 2026
-
Jun 13, 2026, 08:44Omid Seidizadeh: Honored to Present on Advances in VWD Management at EHA 2026
-
Jun 13, 2026, 02:23Ruben Mesa: Honoring MPN Legend Prof. Claire Harrison
-
Jun 13, 2026, 02:09Hassan Raza: ABO Discrepancy Case – Educational Review